Skip to main content

Published locations for ERBB2-positive BC: Adding atezolizumab to PATH shows acceptable pCR rate in phase 2

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ERBB2-positive BC: Adding atezolizumab to PATH shows acceptable pCR rate in phase 2

User login

  • Reset your password
  • /content/erbb2-positive-bc-adding-atezolizumab-path-shows-acceptable-pcr-rate-phase-2
  • /hematology-oncology/article/257213/breast-cancer/erbb2-positive-bc-adding-atezolizumab-path-shows
  • /breast-cancer-icymi/article/257213/breast-cancer/erbb2-positive-bc-adding-atezolizumab-path-shows